Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Ancilia Biosciences develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. The company is developing a proprietary platform that leverages the natural function of CRISPR to produce a new class of live biotherapeutics (LBPs) with engineered immunity to viral phages. These viral phages, […]
Kanvas Bioscience wants to revolutionize microbial research and infectious disease diagnostics with next generation imaging technology that is able to provide deeper information on the spacial organisation and behaviour of microbial communities. The company’s highly multiplexed imaging technology originates from Cornell University and uses a two-step process called high phylogenetic resolution microbiome mapping by fluorescence […]
Bo InnoHealth is a spin-off from the Hong Kong Polytechnic University developing a novel microencapsulation technology which can protect probiotics and probiotics and enable their use in a wider range of applications such as snacks, hot drinks and pet food. The company’s approach is based on using mushroom cells as a protective material to make […]